Table 3.
Variable | NT | ICT | RVT | Treatment Differences | |||||
---|---|---|---|---|---|---|---|---|---|
CHO | CP | CHO | CP | CHO | CP | NT-ICT | ICT-RVT | NT-RVT | |
VO2 (mL·min−1) | 2767 ± 368 | 2704 ± 496 | 2679 ± 404 (P-N) | 2563 ± 418 (L-N) | 2671 ± 389 | 2587 ± 501 (L-N) | −53 ± 190 | 32 ± 204 | −20 ± 275 |
13/47/40 | 33/46/21 | 27/36/37 | |||||||
Unclear | Unclear | Unclear | |||||||
Heart Rate (bt·min−1) | 137 ± 16 | 138 ± 13 | 135 ± 12 | 133 ± 14 (P-N) | 141 ± 15 (P-N) | 134 ± 13 (P-N) | −3 ± 9 | −6 ± 6 | −9 ± 9 |
10/39/51 | 2/24/74 | 2/12/85 | |||||||
Unclear | Possible | Likely | |||||||
RER | 0.81 ± 0.04 | 0.83 ± 0.02 | 0.84 ± 0.11 | 0.80 ± 0.04 (L-N) | 0.87 ± 0.02 (ML-N) | 0.84 ± 0.03 (L-I) | −0.05 ± 0.05 | 0.01 ± 0.08 | −0.04 ± 0.03 |
4/3/93 | 49/12/39 | 2/2/96 | |||||||
Likely | Unclear | Very likely | |||||||
Glucose (mg·dL−1) | 87 ± 8 | 80 ± 6 | 93 ± 7 (L-N) | 83 ± 11 | 91 ± 5 | 86 ± 7 (L-N) | −3 ± 16 | 5 ± 16 | 2 ± 9 |
30/13/57 | 66/11/23 | 56/23/21 | |||||||
Unclear | Unclear | Unclear | |||||||
Lactate (mmol·L−1) | 1.1 ± 0.5 | 1.0 ± 0.5 | 0.9 ± 0.1 | 1.0 ± 0.4 | 1.1 ± 0.6 | 0.9 ± 0.2 | 0.1 ± 0.8 | −0.3 ± 0.7 | −0.2 ± 0.8 |
46/20/35 | 18/24/58 | 31/20/50 | |||||||
Unclear | Unclear | Unclear | |||||||
RPE (6–20) | 12.0 ± 1.0 | 11.7 ± 2.3 | 12.3 ± 1.9 | 12.0 ± 2.2 (P-N) | 11.4 ± 2.2 (L-I) | 11.6 ± 2.2 (P-I) | 0.0 ± 1.1 | 0.4 ± 0.6 | 0.4 ± 1.3 |
44/28/28 | 73/24/3 | 66/18/16 | |||||||
Unclear | Possible | Unclear |
Treatment effects are mean ± 90% CI, % likelihoods positive/trivial/negative effects, and semantic inference. P-N = possibly different than NT, L-N = likely different than NT, VL-N = very likely different than NT, ML-N = most likely different than NT, P-I = possibly different than ICT, L-I = likely different than ICT. NT = normal training; ICT = intensified cycle training; RVT = reduced volume training; CHO = carbohydrate supplementation; CP = carbohydrate + protein supplementation; VO2 = oxygen uptake; RER = respiratory exchange ratio; RPE = rating of perceived exertion.